CELLULAR-IMMUNITY IN HEMODIALYSIS-PATIENTS - A QUANTITATIVE-ANALYSIS OF IMMUNE CELL SUBSETS BY FLOW-CYTOMETRY

被引:41
作者
DEENITCHINA, SS
ANDO, T
OKUDA, S
KINUKAWA, N
HIRAKATA, H
NAGASHIMA, A
FUJISHIMA, M
机构
[1] KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 2,HIGASHI KU,FUKUOKA 812,JAPAN
[2] KYUSHU UNIV,FAC MED,DEPT MED INFORMAT,HIGASHI KU,FUKUOKA 812,JAPAN
关键词
HEMODIALYSIS; IMMUNE CELL SUBSETS; IMMUNODEFICIENCY; TCR CD3 RECEPTOR COMPLEX; 2-COLOR FLOW CYTOMETRY;
D O I
10.1159/000168802
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Immune cell subsets, when measured by two-color flow cytometry in a population of 129 hemodialysis patients, showed significant variance from normal values. Lymphopenia, decreased absolute counts, and altered percentage values of immune cells were found. Increased proportions of CD3+, T cell receptor (TCR) alpha beta+ cells and CD4+ T lymphocytes were present. An abnormally high percentage of a subset of activated TCR alpha beta+ cells (alpha beta+ DR+) was also seen in hemodialysis patients. The proportion of B lymphocytes was found to be significantly lower as compared with controls. Relative values for TCR gamma delta+ cells, both for activated (gamma delta+ DR+) and nonactivated (gamma delta+ DR-) subsets, as well as for CD8+ lymphocytes and natural killer cells did not vary from those of normal controls. Also, the CD4+/CD8+ ratio showed no significant change. Analysis of absolute counts of the investigated immune cell populations revealed significantly decreased numbers for the majority of subsets, as a result of the preexisting lymphocytopenia, characteristic of end-stage renal disease. We conclude that profound quantitative alterations of immune cells, including TCR+ T cells subsets, exist in hemodialysis patients. These account, at least in part, for the immune dysregulation associated with chronic renal failure.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 42 条
[1]  
ALAMARTINE E, 1990, ANN BIOL CLIN-PARIS, V48, P631
[2]   ANALYSIS OF IMMUNE STATUS OF HEMODIALYZED ADULTS - ASSOCIATION WITH PRIOR TRANSFUSIONS [J].
BENDER, BS ;
CURTIS, JL ;
NAGEL, JE ;
CHREST, FJ ;
KRAUS, ES ;
BRIEFEL, GR ;
ADLER, WH .
KIDNEY INTERNATIONAL, 1984, 26 (04) :436-443
[3]  
BORST J, 1983, J BIOL CHEM, V258, P5135
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[5]   PRESENCE OF PREACTIVATED T-CELLS IN HEMODIALYZED PATIENTS - THEIR POSSIBLE ROLE IN ALTERED IMMUNITY [J].
CHATENOUD, L ;
DUGAS, B ;
BEAURAIN, G ;
TOUAM, M ;
DRUEKE, T ;
VASQUEZ, A ;
GALANAUD, P ;
BACH, JF ;
DELFRAISSY, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7457-7461
[6]  
CHATENOUD L, 1981, HUM LYMPHOCYTE DIFF, V1, P131
[7]  
Chatenoud L, 1990, Adv Nephrol Necker Hosp, V19, P259
[8]  
CHATENOUD L, 1994, KIDNEY INT S44, V45, P92
[9]  
CHIDA Y, 1986, CLIN NEPHROL, V25, P159
[10]   USE OF MONOCLONAL-ANTIBODIES TO T-CELL SUBSETS FOR IMMUNOLOGICAL MONITORING AND TREATMENT IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
COSIMI, AB ;
COLVIN, RB ;
BURTON, RC ;
RUBIN, RH ;
GOLDSTEIN, G ;
KUNG, PC ;
HANSEN, WP ;
DELMONICO, FL ;
RUSSELL, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (06) :308-314